The Application of Pulmonary Inhalation Technology to Drug Discovery

Annual Reports in Medicinal Chemistry

Volumn 41, Issue , 2006, Pages 383-393

  Clark, A R ^a   Wolff, R K ^a   Eldon, M A ^a   Dwivedi, S K ^a  

^a NEKTAR THERAPEUTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846371993     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(06)41026-5     Document Type: Review

References (51)

1. A. R. Clark, in Inhalation Aerosols: Physical and Biological Basis for Therapy (ed. A. J. Hickey), 2nd edition. Taylor & Francis Inc., New York, 2004.
2. Patton J.S. Adv. Drug Deliver. Rev. 19 (1996) 3-36
3. Patton J.S., Fishburn S.C., and Weers J.G. Proc. Am. Thorax Soc. 1 (2004) 338-344
4. Weibel E.R. Morphometry of the Human Lung (1963), Springer-Verlag, Berlin
5. Bend J.R., Hook G.E.R., and Gram T.E. Drug Metab. Dispos. 1 (1972) 358-367
6. Matsusbara T., Prough R.A., Burke M.D., and Estabrook R.W. Cancer Res. 34 (1974) 2196-2203
7. Borgstrom L., and Nilsson M. Pharm. Res. 7 (1990) 1068
8. Consensus statement from a workshop of the British Association for Lung Research, Respir. Med., 1999, 93, 123-133.
9. Weibel E.R. Respiratory Physiology: An Analytical Approach (1989), Marcel Dekker, New York 1-56
10. Rudolf G., Kobirch R., and Stahlhofen W. J. Aerosol. Sci. 21 (1990) S403-S406
11. G. E. Hatch, in: Treatise on Pulmonary Toxicology: Comparative Biology of the Normal Lung (ed. R. A. Parent), CRC Press, Boca Raton, FL, 1992, 617-632.
12. Stephens R.H., Benjamin A.R., and Walters D.V. J. Appl. Physiol. 80 (1996) 1911-1920
13. Shanker L.S. Biochem. Pharmacol. 27 (1978) 381-385
14. Monk J.P., and Benfield P. Drugs 39 (1990) 741-756
15. Patton J.S., Bukar J., and Nagarajan S. Adv. Drug Deliver. Rev. 35 (1999) 235-247
16. Stoeck M., Riedel R., Hocchaus G., Häfner D., Masso J.M., Schmidt B., Hatzelmann D., and Bundschuh D.S. J. Pharmacol. Exp. Ther. 309 (2004) 249-258
17. L. Borgstrom, H. Bisgaard, C. O'Callaghan and S. Pedersen, in Drug Delivery to the Lungs (eds. H. Bissgard, C. O'Callaghan and G. C. Samldone), Marcel Dekker, New York, 2002, 421-448.
18. C. O'Callaghan and P. Wright, in Drug Delivery to the Lungs (eds. H. Bissgard, C. O'Callaghan and G. C. Samldone), Marcel Dekker, New York, 2002, 337-370.
19. A. L. Adjei, Y. Qiu and P. Gupta, in Inhalation Aerosols (ed. A. J. Hickey), Marcel Dekker, New York, 1996, 197-228.
20. S. J. Farr, J. A. Schuster, P. Lloyd, L. J. Lloyd, J. K. Okikawa and R. M. Rubsamen, in Respiratory Drug Delivery VIII (eds. R. N. Dalby, P. R. Byron and S. J. Farr), Interpharm Press, Tucson, AZ, 1996, 175-185
21. Taburet A.M., and Schmit B. Clin. Pharmacokinet. 26 5 (1994) 396-418
22. Sears M.R., and Lovall J. Respir. Med. 99 2 (2005) 152-170
23. Wolff R.K. J. Aerosol Med. 11 (1998) 197-219
24. R. K. Wolff, D. Clarke, M. Carfagna, M. Stoiff, H. Smith, M. Shaw, L. Johnston, B. Jackson and D. Edwards, Congress of International Society of Aerosol in Medicine, Baltimore, MD, June 14-18, 2003.
25. J. Pauluhn and T. Martins, Proceedings of the Fourth International Aerosol Conference, Los Angeles, CA, 1994, p. 683 (abstract).
26. Green J.D. Hum. Exp. Toxicol. 13 suppl (1994) Sl-S42
27. Adjei A.L. J. Aerosol Med. 8 (1995) 131
28. United States Food and Drug Administration, Summary Basis of Approval for Dornase A1fa, recombinant Pulmozyme Inhalation Solution, 1993, FDA, Washington, DC.
29. United States Food and Drug Administration, Summary Basis of Approval for Tobramycin, 1997, FDA Washington, DC.
30. J. S. Patton and R. M. Platz, in Respiratory Drug Delivery IV (eds. P. R. Byron, R. N. Dalby and S. J. Farr), Interpharm Press, Buffalo Grove, IL, 1994, 65-74.
31. T. D. Sweeney, M. Marian, K. Achilles, J. Bussiere, J. Ruppel, M. Shoenhoff and R. J. Mrsny, in Respiratory Drug Delivery VII. (eds. R. N. Dalby, P. R. Byron, S. J. Farr and J. Peart), Serentec Press, Tarpon Springs, FL, 2000, 59-66.
32. M. E. Placke, W. C. Zimlich, J. Y. Ding, D. J. Westaway and A. R. Imodi, in Respiratory Drug Delivery VIII (eds. R. N. Dalby, P. R. Byron, J. Peart and S. J. Farr), Davis Horword International Publishing, Tucson, AZ, 2002, 15-23.
33. Dryer M. Diabetologia 47 suppl 1 (2004) A44
34. Heise T., Bott S., Tusek C., Stephan J.-A., Kawabata T., Finco-Kent D., Liu C., and Krasner A. Diabetes Care 28 (2005) 2161-2169
35. Fineberg S.E., Kawabata T., Finco-Kent D., Liu C., and Krasner A. J. Clin. Edocrinol. Metab. 90 (2005) 3280-3294
36. ® [Package insert], 2006, Pfizer Inc., New York, NY.
37. Hall C.B. J. Aerosol Med 2 (1989) 221-231
38. Kinnula V., Cantell K., and Mattson K. Eur. J. Cancer 26 (1990) 740-741
39. Martin R.J., Boguniewicz M., Henson J.E., Celniker A.C., Williams M., Giorno R.C., and Leung. D.Y. Am. Rev. Respir. Dis. 148 (1993) 677-1682
40. McElvaney N.G., Hubbard R.C., Birrer P., Chernick M.S., Caplan D.B., Frank M.M., and Crystal R.G. Lancet 337 (1991) 392-394
41. Patton J.S., and Platz R.M. Adv. Drug Deliv. Rev. 8 (1992) 179-196
42. Boulet L.P., Chapman K.R., Cote J., Kalra S., Bhagat R., Swystun V.A., Laviolette M., Cleland L.D., Deschesnes F., Su J.Q., DeVault A., Vick R.B., and Cockcroft D.W. Am J. Respir. Crit. Care Med. 155 (1997) 1835-1840
43. Kohler D. J. Aerosol Med. 7 (1994) 307-314
44. Ilowite J.S., Gorvoy J.D., and Smaldone G.C. Am. Rev. Respir. Dis. 136 (1987) 1445-1449
45. Courrier H.M., Butz N., and Vandamme T.F. Crit. Rev. Ther. 19 (2002) 425-498
46. Groneberg D.A., Witt C., Wagner U., Chung K.F., and Fischer A. Resp. Med. 97 (2003) 382-387
47. Labiris N.R., and Dolovich M.B. Brit. J. Clin. Pharmacol. 56 (2003) 600-612
48. Combs D.W., Rampulla M.S., Russel R.K., Rampulla R.A., Klaubert D.H., Ritchie D., Meeks A.S., and Kirchner T. Drug Des. Deliv. 6 (1990) 241-254
49. FDA draft guidance for nasal spray and inhalation solutions, suspensions and spray drug products, May 1999.
50. Jack D. Drug Safety 5 suppl. 1 (1990) 4-23
51. Szelenyi I., Hocchaus G., Heer S., Küsters S., Marx D., Poppe H., and Engel J. Drugs Today 36 (2000) 313-320